Lumida
/BTMD
⌘K
Biote Corp

Biote Corp

BTMD
$1.33USD↑+1.53%+0.02 today

MARKET CAP

47.8M

P/E (TTM)

3.0x

FWD P/E

—

DAY RANGE

$1 – $1

52W RANGE

$1
$4

AI Summary

Stalk
TrimMedium

Price remains in a medium- and long-term downtrend following an early-August support failure, and despite extreme oversold readings, the structural bias favors bearish execution. Selling on a rebound into the broken support zone or moving averages (around $1.47–$1.56) aligns with resistance rejection. Defer outright selling now and wait for a minor rally into key resistance to trim positions.

  • ↑Product recall resolved; production and margins to normalize by H2 2026.
  • ↑Insider buying: Exec chairman acquired ~131,950 shares for $202K.
  • ↓Q2 2026 net loss $0.23/sh versus $0.03 profit expected.
Full analysis →

Buying

5

institutions

Selling

3

institutions

New Positions

3

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
MM

Millennium Management LLC

Q2 2026

BUYNEW436.09 K824.21 K+436.09 K+0.0%0.00%
BI

Blackrock, Inc.

Q2 2026

SELL365.94 K691.64 K+-1.37 M-70.5%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUYNEW301.31 K569.48 K+301.31 K+0.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY251.62 K475.56 K+197.96 K+556.5%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL229.99 K434.69 K+-35.92 K+21.1%0.00%
MG

Man Group Plc

Q2 2026

BUY70.14 K132.57 K+5.32 K+51.5%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUYNEW14.56 K27.53 K+14.56 K+0.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL8.77 K14.64 K+-10.69 K-42.1%0.00%